One-Man Equity Shop Returns 256% Since 2012 Without FAANGs

(Bloomberg) -- Jonathan Tanne first heard about Amarin Corp.’s fish-oil pill in 2016. He met its chief executive officer, spoke to cardiologists and parsed academic papers before deciding in 2017 t...